Sanofi, Israel’s Biond Biologics to team up for new cancer drug
Biond said that it will receive a $125 million upfront payment in cash under the deal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer immunotherapies
Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer…
Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers